Generic API’s have been an integrant part of Hovione’s business for the past 50 years. Throughout this period, we have supplied more than 45 generic API’s to the most demanding customers in the United States, Europe and Japan. Our products have been used in the most challenging drug product formulations.

Hovione has an excellent track record focused on developing and manufacturing difficult API’s which provides an extensive understanding of the challenges and opportunities that exist in generic API’s. Hovione is recognized as a major supplier of high quality API products in the field, and has been supplying the most regulated markets with corticosteroids since the 1960´s.

Betamethasone sodium phosphate, manufactured by Hovione, is isolated by spray-drying technology and exhibits high chemical quality and complies with acceptance criteria set in the Japanese and USP pharmacopeia monographs for this drug substance.

Hoviones’ Spray-drying equipments includes a wide range of versatile and multi-scale equipments, which means we can manufacture gram scale quantities for feasibility studies and clinical trials or full commercial scale batches while guaranteeing full cGMP compliance.

Hoviones dynamic and experienced Product Team has combined the spray-drying know-how with betamethasone sodium phosphate drug substance understanding and successfully developed a manufacturing process that produces betamethasone sodium phosphate that meets our Customers needs.

Hovione is focused on developing a lifetime partnership with its Customers, which will allow for synergistic opportunities to reduce time in drug development, and to offer customers’ the benefit of a one-stop-shop solution.

Betamethasone sodium phosphate website provides you with information about the regulatory and inspection status and it gives you an overall view of the facility where the drug substance is manufactured.